Brainfarma

Brainfarma, established in 2002, stands as a prominent pharmaceutical manufacturer within the Brazilian healthcare sector. The company focuses on the development and production of high-quality pharmaceutical products, nutritional supplements, and dermocosmetics. By prioritizing continuous innovation and sustainable growth, Brainfarma aims to improve the quality of life for the Brazilian population through rigorous research and development standards.

The company operates a large-scale manufacturing facility located in Anápolis, which maintains the capacity to produce over 830 distinct items across various pharmaceutical forms. Complementing this production capability, Brainfarma maintains a state-of-the-art innovation center in Barueri. This facility is specifically dedicated to advancing research in dermocosmetics, vitamin supplements, and nutritional products, ensuring the company remains at the forefront of pharmaceutical technology and health solutions.

With a workforce of 1,000-5,000 employees, Brainfarma maintains a significant operational footprint in South America. The company reports annual revenue of $155.6M, reflecting its strong market position and commitment to operational excellence. Meet Brainfarma's team to learn more about the leadership driving these initiatives. Brainfarma continues to emphasize social responsibility and integrity as core pillars of its corporate strategy, solidifying its reputation as a key player in the regional pharmaceutical industry. The firm leverages its extensive R&D capabilities to address diverse healthcare needs, consistently delivering high-quality products that meet stringent regulatory standards while fostering long-term growth within the competitive Brazilian market.